Page 1114 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1114

Chapter 81







                     REFERENCES


                       1. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-    15. Holty JE, Bravata DM, Liu H, Olshen RA, McDonald KM,
                        related inhalational anthrax: the first 10 cases reported in the   Owens DK. Systematic review: a century of inhalational anthrax
                        United States. Emerg Infect Dis. 2001;7:933-944.        cases from 1900 to 2005. Ann Intern Med. 2006;144:270-280.
                       2. Schutzer SE, Budowle B, Atlas RM. Biocrimes, microbial foren-    16. Bravata DM, Holty JE, Wang E, et al. Inhalational, gastro-
                        sics, and the physician. PLoS Med. 2005;2:e337.         intestinal, and cutaneous anthrax in children: a systematic
                       3. Bioterrorism Prevention: Interpol; 2010.  http://www.interpol   review of cases: 1900 to 2005.  Arch Pediatr Adolesc Med.
                        .int/Public/BioTerrorism/default.asp                    2007;161:896-905.
                       4. Bioterrorism Overview: Centers for Disease Control and     17. Brookmeyer R, Johnson E, Barry S. Modelling the incubation
                        Prevention; 2010. http://www.bt.cdc.gov/bioterrorism/overview.asp  period of anthrax. Stat Med. 2005;24:531-542.
                       5. Carus  WS.  Bioterrorism and Biocrimes: The illicit use of     18. Ketai L, Alrahji AA, Hart B, Enria D, Mettler F Jr. Radiologic
                        biological agents since 1900. Washington, D.C.: Center for   manifestations of potential bioterrorist agents of infection. AJR
                        Counterproliferation Research, National Defence University;   Am J Roentgenol. 2003;180:565-575.
                        2001.                                                19. Ketai L, Tchoyoson Lim CC. Radiology of biological weapons—
                       6. Bioterrorism agents by diseases/category: Center for Disease   old and the new? Semin Roentgenol. 2007;42:49-59.
                        Control and Prevention; 2010.  http://www.bt.cdc.gov/agent/    20. Krol CM,  Uszynski  M, Dillon EH,  et al. Dynamic  CT fea-
                        agentlist-category.asp                                  tures of inhalational anthrax infection.  AJR Am J Roentgenol.
                       7. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM.   2002;178:1063-1066.
                        Public health assessment of potential biological terrorism     21. Wood  BJ,  DeFranco  B,  Ripple  M,  et  al.  Inhalational  anthrax:
                        agents. Emerg Infect Dis. 2002;8:225-230.               radiologic and pathologic findings in two cases.  AJR Am  J
                       8. Cashman JR. Emergency Response Handbook for Chemical and   Roentgenol. 2003;181:1071-1078.
                        Biological Agents and Weapons. Boca Raton: CRC Press; 2008.    22. Frazier AA, Franks TJ, Galvin JR. Inhalational anthrax. J Thorac
                       9. English  J.  Bioterrorism readiness planning suggestions.   Imaging. 2006;21:252-258.
                        Washington, D.C.: Association of Professionals in Infection     23. Lanska DJ.  Anthrax  meningoencephalitis.  Neurology.
                        Control and Epidemiology, Inc.; 2002.  http://www.apic   2002;59:327-334.
                        .org/Content/NavigationMenu/PracticeGuidance/Topics/    24. Ashkenazi-Hoffnung L, Kaufman Z, Bromberg M, et al.
                        Bioterrorism/APIC_BTWG_BTRSugg.pdf                      Seasonality of Bacillus species isolated from blood cultures and
                      10. Roy  CJ,  Reed  DS,  Hutt  JA.  Aerobiology  and  inhalation   its potential implications. Am J Infect Control. 2009;37:495-499.
                        exposure to biological select agents and toxins.  Vet Pathol.     25. Anthrax: Treatment: Centers for disease control and prevention;
                        2010;47:779-789.                                        2010. http://emergency.cdc.gov/agent/anthrax/treatment/
                      11. Sobel J, Khan AS, Swerdlow DL. Threat of a biological terror-    26. Fact sheet: anthrax information for health care providers:
                        ist attack on the US food supply: the CDC perspective. Lancet.   Centers  for disease control and prevention; 2010.  http://
                        2002;359:874-880.                                       emergency.cdc.gov/agent/anthrax/anthrax-hcp-factsheet.asp
                      12. Franz DR. Preparedness for an anthrax attack. Mol Aspects Med.     27. Inglesby TV, Grossman R, O’Toole T. A plague on your city:
                        2009;30:503-510.                                        observations from TOPOFF. Clin Infect Dis. 2001;32:436-445.
                      13. Swartz MN. Recognition and management of anthrax—an     28. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biolog-
                        update. N Engl J Med. 2001;345:1621-1626.               ical weapon: medical and public health management. Working
                      14. Stern  EJ, Uhde  KB, Shadomy SV, Messonnier  N. Conference   Group on Civilian Biodefense. JAMA. 2000;283:2281-2290.
                        report on public health and clinical guidelines for anthrax.     29. Plague fact sheet: Centers for disease control and prevention;
                        Emerg  Infect Dis.  2008;14(4):pii:07-0969.  http://wwwnc.cdc   2010.  http://www.cdc.gov/ncidod/dvbid/plague/resources/
                        .gov/eid/article/14/4/07-0969_article.                  plagueFactSheet.pdf










            Section05-O-ref.indd   1                                                                                   1/20/2015   4:51:26 PM
   1109   1110   1111   1112   1113   1114   1115   1116   1117   1118   1119